CCL26 and Increased total eosinophil count: When those patients are treated with PPIs, the proximal esophagus responds to the acid-independent, anti-inflammatory PPI effects in suppressing eotaxin-3, and the decreased expression of this eosinophil chemoattractant results in a commensurate reduction in proximal esophageal eosinophilia (Figure 9D).